China Universal Asset Management Co., Ltd. Editas Medicine, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 16,558 shares of EDIT stock, worth $27,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,558
Previous 17,503
5.4%
Holding current value
$27,320
Previous $22,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding EDIT
# of Institutions
226Shares Held
54.4MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$12.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$11.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$4.53 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$3.56 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$3.09 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $113M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...